Insider Trading26 Jun 2026, 12:55 pm
Marksans Pharma Closes Trading Window for Q1 FY27
AI Summary
Marksans Pharma Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The exact date of the results declaration will be communicated separately. During this period, no trading in the company's shares is permitted for these individuals.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from July 1, 2026.
- Period extends 48 hours post Q1 FY27 results declaration.
- Aims to prevent insider trading.
- No trading allowed during the specified period.
Price Impact
More from MARKSANS